The global robotic process automation in healthcare market size accounted for USD 2.22 billion in 2024, grew to USD 2.80 billion in 2025 and is projected to surpass around USD 22.56 billion by 2034, representing a healthy CAGR of 26.10% between 2024 and 2034. The North America ABC market size is calculated at USD 950 million in 2024 and is expected to grow at a fastest CAGR of 26.18% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Robotic Process Automation In Healthcare Market
5.1. COVID-19 Landscape: Robotic Process Automation In Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Robotic Process Automation In Healthcare Market, By Solution
8.1. Robotic Process Automation In Healthcare Market, by Solution, 2024-2034
8.1.1 Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Implementation
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Support and Maintenance
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Training and Consulting
8.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Robotic Process Automation In Healthcare Market, By Operations
9.1. Robotic Process Automation In Healthcare Market, by Operations, 2024-2034
9.1.1. Rule-based Operation
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Knowledge-based Operation
9.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Robotic Process Automation In Healthcare Market, By Application
10.1. Robotic Process Automation In Healthcare Market, by Application, 2024-2034
10.1.1. Claims Management
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Clinical Documentation
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Billing and Compliance Management
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Appointment Scheduling
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Workflow Management
10.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Robotic Process Automation In Healthcare Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Solution (2021-2034)
11.1.2. Market Revenue and Forecast, by Operations (2021-2034)
11.1.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Solution (2021-2034)
11.2.2. Market Revenue and Forecast, by Operations (2021-2034)
11.2.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Solution (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Operations (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Solution (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Operations (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Solution (2021-2034)
11.3.2. Market Revenue and Forecast, by Operations (2021-2034)
11.3.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Solution (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Operations (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Solution (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Operations (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Solution (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Operations (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Solution (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Operations (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Solution (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Operations (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Solution (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Operations (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
Chapter 12. Company Profiles
12.1. Blue Prism
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. UiPath
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Automation Anywhere
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Kofax
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Jidoka
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Kryon Systems
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. EdgeVerve Systems
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. PegaSystems
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Another Monday
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample